1
|
Kirkman MS, Tripputi M, Krause-Steinrauf H, Bebu I, AbouAssi H, Burch H, Duran-Valdez E, Florez H, Garvey WT, Hsia DS, Salam M, Pop-Busui R. Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2024; 47:594-602. [PMID: 38194519 PMCID: PMC10973908 DOI: 10.2337/dc23-1332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Accepted: 11/03/2023] [Indexed: 01/11/2024]
Abstract
OBJECTIVE In Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) (5,047 participants, mean follow-up 5.0 years), differences in glycemic control were demonstrated over time among four randomized therapies added to metformin. Weight gain and hypoglycemia are also important outcomes for people with type 2 diabetes. We compared the effects of the four randomized GRADE medications on a composite outcome incorporating glycemic deterioration, weight gain, and hypoglycemia. RESEARCH DESIGN AND METHODS The composite outcome was time to first occurrence of any of the following: HbA1c >7.5%, confirmed; ≥5% weight gain; or severe or recurrent nonsevere hypoglycemia. Secondary analyses included examination of individual components of the composite outcome, subgroup effects and potential mediators, and treatment satisfaction. Cumulative incidence was estimated with the Kaplan-Meier estimator. Cox proportional hazards models were used to assess pairwise group differences in risk of an outcome. RESULTS Risk of reaching the composite outcome (events per 100 participants per treatment year [PTYs]) was lowest with liraglutide (19 per 100 PTYs) followed by sitagliptin (26 per 100 PTYs), glargine (29 per 100 PTYs), and glimepiride (40 per 100 PTYs); all pairwise comparisons were statistically significant. The order was the same for risk of weight gain and hypoglycemia, but risk of glycemic deterioration was lowest with glargine, followed by liraglutide, glimepiride, and sitagliptin. No significant heterogeneity in risk of composite outcome was detected across prespecified covariates. Participants who reached the composite outcome had modestly but significantly lower treatment satisfaction. CONCLUSIONS Among participants treated with common second-line drug classes for type 2 diabetes, the liraglutide group had the lowest and glimepiride the highest risk of reaching a composite outcome encompassing glycemic deterioration, weight gain, and hypoglycemia. These findings may inform decision-making regarding type 2 diabetes therapy.
Collapse
Affiliation(s)
- M. Sue Kirkman
- University of North Carolina at Chapel Hill, Chapel Hill, NC
| | - Mark Tripputi
- The Biostatistics Center, Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, The George Washington University, Rockville, MD
| | - Heidi Krause-Steinrauf
- The Biostatistics Center, Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, The George Washington University, Rockville, MD
| | - Ionut Bebu
- The Biostatistics Center, Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, The George Washington University, Rockville, MD
| | | | - Henry Burch
- National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Rockville, MD
| | | | - Hermes Florez
- Department of Medicine, University of Miami, Miami, FL
- Medical University of South Carolina, Charleston, SC
| | | | | | - Maamoun Salam
- Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO
| | - Rodica Pop-Busui
- Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI
| |
Collapse
|
2
|
Liao S, Hasan M, Humphrey R, Yang Z, Crenshaw M, Brett J, Rude B, Burch H. PSV-24 The mineral profile of GuarPro F-71, a potential protein source for swine and other agricultural animals in the United States. J Anim Sci 2018. [DOI: 10.1093/jas/sky404.720] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- S Liao
- Department of Animal & Dairy Sciences, Mississippi State University,Mississippi State, MS 39762, Mississippi State, MS, United States
| | - M Hasan
- Department of Animal & Dairy Sciences, Mississippi State University,Mississippi State, MS 39762, Mississippi State, MS, United States
| | - R Humphrey
- Department of Animal & Dairy Sciences, Mississippi State University,Mississippi State, MS 39762, Mississippi State, MS, United States
| | - Z Yang
- Department of Animal & Dairy Sciences, Mississippi State University,Mississippi State, MS 39762, Mississippi State, MS, United States
| | - M Crenshaw
- Department of Animal & Dairy Sciences, Mississippi State University,Mississippi State, MS 39762, Mississippi State, MS, United States
| | - J Brett
- Department of Animal & Dairy Sciences, Mississippi State University,Mississippi State, MS 39762, Mississippi State, MS, United States
| | - B Rude
- Department of Animal & Dairy Sciences, Mississippi State University,Mississippi State, MS 39762, Mississippi State, MS, United States
| | - H Burch
- Nutrix Organics, USA, Lafayette, LA, United States
| |
Collapse
|
3
|
Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M. Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 2001; 61:6105-11. [PMID: 11507060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
Enhanced activation of Akt occurs in Cowden's disease, an inherited syndrome of follicular thyroid, breast, colon, and skin tumors, via inactivation of its regulatory protein, PTEN. Whereas PTEN inactivation is uncommon in sporadic thyroid cancer, activation of growth factor pathways that signal through Akt is frequently identified. We hypothesized that Akt overactivation could be a common finding in sporadic thyroid cancer and might be important in thyroid cancer biology. We examined thyroid cancer cells lines and benign and malignant thyroid tissue for total Akt activation and isoform-specific Akt expression. In thyroid cancer cells, Akt 1, 2, and 3 proteins were expressed, total Akt was activated by insulin phosphatidylinositol 3'-kinase, and inhibition of phosphatidylinositol 3'-kinase reduced cell viability. In human thyroid tissue, increased levels of phosphorylated total Akt were identified in follicular but not papillary cancers compared with normal tissue. Levels of Akt 1 and 2 proteins and Akt 2 RNA were elevated only in the follicular cancers. In paired samples, Akt 1, 2, 3, and phospho-Akt levels were higher in five of six cancers, including three of three follicular cancers. These data suggest that Akt activation may play a role in the pathogenesis or progression of sporadic thyroid cancer.
Collapse
Affiliation(s)
- M D Ringel
- Washington Hospital Center and MedStar Research Institute, Washington, DC 20010, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Morris-Wiman J, Burch H, Basco E. Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis. Anat Embryol (Berl) 2000; 202:129-41. [PMID: 10985432 DOI: 10.1007/s004290000098] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Extracellular matrix (ECM) molecules are known to play a pivotal role in the morphogenesis of the secondary palate. The maintenance and degradation of the ECM is mediated in part by the matrix metalloproteinases (MMPs) and their endogenous inhibitors TIMPs. MMPs and TIMPs have previously been shown to be developmentally regulated within the palatal shelf during secondary palate morphogenesis. This study was conducted to examine the temporospatial distribution of these enzymes and their inhibitors within the palatal shelves using immunofluorescent localization to determine if specific changes occur in their distribution concomitant with events in palatal shelf formation and reorientation. Frontal sections through the posterior palatal shelves at gestational day (gd) 12, 13 and 14 were immunofluorescently stained for MMPs 2, 3, 9, and 13 and TIMPs 1, 2, and 3 using standard protocols and commercially available antibodies. The results demonstrated that MMPs and TIMPs were already present within the palatal shelf mesenchyme 30 h prior to reorientation and closure and that their expression within the shelf mesenchyme increased as the shelves remodeled, then decreased with closure and fusion. Increased distribution of MMPs and TIMPs within specific regions of the palatal mesenchyme and palatal epithelial basement membrane preceded decreases previously observed within these areas for their substrates, fibronectin, collagen III and collagen I. In addition, MMP-3 and TIMP-3 were immunolocalized to regions of the palatal epithelium that undergo reorganization concomitant with reorientation. The results of this study indicate that MMPs and TIMPs are developmentally regulated during palatal shelf morphogenesis and that their distribution correlates with the distribution of the ECM components of the palatal shelf they regulate. These results provide support for the idea that temporospatially controlled interactions between MMPs and their substrates may be pivotal in modulating events in palatal morphogenesis.
Collapse
Affiliation(s)
- J Morris-Wiman
- Department of Orthodontics, College of Dentistry, University of Florida, Gainesville 32610-0444, USA.
| | | | | |
Collapse
|
5
|
Rimoldi JM, Wang YX, Nimkar SK, Kuttab SH, Anderson AH, Burch H, Castagnoli N. Probing the mechanism of bioactivation of MPTP type analogs by monoamine oxidase B: structure-activity studies on substituted 4-phenoxy-, 4-phenyl-, and 4-thiophenoxy-1-cyclopropyl-1,2,3,6-tetrahydropyridines. Chem Res Toxicol 1995; 8:703-10. [PMID: 7548753 DOI: 10.1021/tx00047a010] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Previous studies have shown that 4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridine is an excellent monoamine oxidase B (MAO-B) substrate (kappa cat/KM = 1538 min-1 mM-1) although the corresponding 4-phenyl analog displays MAO-B inactivating properties only. This behavior led us to speculate that the pathway for the MAO-B catalyzed oxidation of these tetrahydropyridines may not necessarily proceed via an initial single electron transfer step as proposed by others but rather through an initial alpha-carbon hydrogen atom abstraction step. In the present studies we have examined the interactions of various 4-phenoxy-, 4-phenyl-, and 4-thiophenoxy-1-cyclopropyl-1,2,3,6-tetrahydropyridine derivatives, some of which bear substituents on the phenyl ring. The 4-thiophenoxy- and all of the 4-phenoxytetrahydropyridine derivatives proved to be substrates but not inactivators of MAO-B, while several of the 4-phenyltetrahydropyridine derivatives were inactivators but not substrates. A case of particular interest was 1-cyclopropyl-4-(2-methylphenyl)-1,2,3,6-tetrahydropyridine, which displayed only substrate properties. The results are discussed in terms of two catalytic pathways, one of which involves partitioning of the proposed cyclopropylaminyl radical cation intermediate between cyclopropyl ring opening and proton loss while the second involves partitioning of the parent amine between an initial single electron transfer step, leading to cyclopropylaminyl radical cation formation and enzyme inactivation, and an initial alpha-carbon hydrogen atom abstraction step, leading to an allylic radical and dihydropyridinium product formation.
Collapse
Affiliation(s)
- J M Rimoldi
- Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg 24061-0212, USA
| | | | | | | | | | | | | |
Collapse
|
6
|
Abstract
Fifty-nine supracondylar-intercondylar fractures of the femur in 57 patients were evaluated after a mean follow-up of 5 years 7 months (range 2 years to 11 years 3 months) after internal fixation using AO/ASIF technique. Axial alignment was compared with that of the uninjured side by orthoroentgenography in the upright position and by bilateral anteroposterior (AP) and lateral views of the femur. Identical values for varus/valgus were noted in 24%, for ante/recurvation in 72%, and for rotation in 61%; differences were within 5 degrees of varus/valgus in 74%, of ante/recurvation in 78%, and of rotation in 83%. Alignment differences were more frequent in complicated and intercondylar fractures according to the AO classification of fractures. We conclude that restoration of the distal femoral angle is far more difficult than restoration of the sagittal plane and rotation, but a satisfactory functional result appears to be compatible with angulation differences of less than or equal to 5 degrees in any plane and that this difference appears to be within the reasonably achievable limits. 93% of the patients were satisfied; 64% of patients were pain-free, and 27% had slight intermittent pain (not interfering with daily activity); 67% of the patients had unlimited walking distance, and 78% of the patients were able to walk without aid. Excellent and good results according to the rating systems of Neer et al., Pritchett, and Schatzker and Lambert were noted in 82, 39, and 26%, respectively. This discrepancy between alignment, pain, function, and results according to different rating systems underlines the need for future standardized, clearly defined reporting and classification of rating.
Collapse
Affiliation(s)
- M K Zehntner
- Department of Orthopedic Surgery, University of Berne Inselspital, Switzerland
| | | | | | | |
Collapse
|
7
|
Abstract
Fifteen patients with fractures of the extremities and associated arterial injuries treated from 1976 to 1987 were retrospectively analyzed. Complete ischemia was present in only two cases; in four cases with partial ischemia, the vascular injury presented late after 12 h-14 days. All limbs could be preserved, but complications were frequent and necessitated 28 operations. Complications were less frequent in primary external fixation of lower-extremity lesions compared with internal fixation. Normal function was regained only in closed fractures or in the absence of discontinuous nerve lesions. It is concluded that short-term salvage of these severe combined injuries depends on the degree and duration of deficient perfusion, but the mid- to long-term functional result depends on the severity of skin, muscle, bone, and nerve injury. The high salvage rate is attributed to the short delay to arterial reconstruction in complete ischemia and the restoration of circulation in isolated tibial artery injuries in partial ischemia cases.
Collapse
Affiliation(s)
- M K Zehntner
- Department of Orthopedic Surgery, University of Berne Inselspital, Switzerland
| | | | | |
Collapse
|